Comment on Shao et al.'s "Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic"
J Med Virol
.
2024 Jan;96(1):e29383.
doi: 10.1002/jmv.29383.
Authors
Hsiu-Ming Lee
1
,
Po-Cheng Shih
2
3
,
James Cheng-Chung Wei
2
4
5
Affiliations
1
School of Medicine, China Medical University, Taichung, Taiwan.
2
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
3
Department of Allergy, Immunology and Rheumatology, Changhua Christian Hospital, Changhua, Taiwan.
4
Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
5
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
PMID:
38180246
DOI:
10.1002/jmv.29383
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19* / epidemiology
China / epidemiology
Humans
Pandemics
Risk Factors
SARS-CoV-2*